Legionella pneumonia with acute respiratory distress syndrome, myocarditis and septic shock successfully treated with Drotrecogin Alpha (activated) [2]

European Journal of Anaesthesiology

Volumn 23, Issue 9, 2006, Pages 808-810

  Bodur, H ^a   Savran, Y ^a   Koca, U ^a   Kilinc O ^a   Albayrak, S ^a   Itil, O ^a   Akoglu S ^b  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

^b MUSTAFA KEMAL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; BACTERIAL ANTIGEN; CLARITHROMYCIN; DOPAMINE; DROTRECOGIN; FUROSEMIDE; LEVOFLOXACIN; RIFAMPICIN;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ANTIGEN DETECTION; CASE REPORT; COMMUNITY ACQUIRED PNEUMONIA; DISEASE EXACERBATION; DRUG EFFICACY; HUMAN; LEGIONELLA PNEUMONIA; LEGIONELLA PNEUMOPHILA; LEGIONNAIRE DISEASE; LETTER; MALE; MULTIPLE ORGAN FAILURE; MYOCARDITIS; SEPTIC SHOCK; SERODIAGNOSIS; TREATMENT OUTCOME; TREATMENT RESPONSE; TURKEY (REPUBLIC); URINALYSIS; VENTILATOR;

ADULT; ANTI-INFECTIVE AGENTS; ECHOCARDIOGRAPHY; HUMANS; LEGIONNAIRES' DISEASE; MALE; MYOCARDITIS; PROTEIN C; RECOMBINANT PROTEINS; RESPIRATORY DISTRESS SYNDROME, ADULT; TREATMENT OUTCOME;

EID: 33746867118     PISSN: 02650215     EISSN: 13652346     Source Type: Journal    
DOI: 10.1017/S0265021506221252     Document Type: Letter

References (9)

1. Ely EW, Laterre PF, Angus DC et al. PROWESS Investigators. Drotrecogin alfa (activated) administration across clinically important subgroups of patients with severe sepsis. Crit Care Med 2003; 31(1): 12-19.
2. van Riemsdijk-van Overbeeke IC, van den Berg. Severe Legionnaire's disease requiring intensive care treatment. Neth J Med 1996; 49(5): 196-201.
3. Gacouin A, Le Tulzo Y, Lavoue S et al. Severe pneumonia due to Legionella pneumophila: prognostic factors, impact of delayed appropriate antimicrobial therapy. Intensive Care Med 2002; 28(6): 686-691.
4. el-Ebiary M, Sarmiento X, Torres A et al. Prognostic factors of severe Legionella pneumonia requiring admission to ICU. Am J Respir Crit Care Med 1997; 156(5): 1467-1472.
5. Karim A, Ahmed S, Rossoff LJ. Legionnaire's disease associated with acute encephalitis and arrhythmia. Crit Care Med 2002; 30(5): 1028-1029.
6. Grangeon V, Vincent L, Pacheco Y. Digestive disorders and Legionnaires' lung disease. Accompanying signs or visceral location? Rev Mal Resp 2000; 17(2): 489-492.
7. Hirani NA, Macfarlane JT. Impact of management guidelines on the outcome of severe community acquired pneumonia. Thorax 1997; 52(1): 17-21.
8. Rello J, Quintana E, Ausina V, Net A, Prats G. A three year study of severe community-acquired pneumonia with emphasis on outcome. Chest 1993; 103(1): 232-235.
9. Laterre PF, Garber G, Levy H et al. For the PROWESS Clinical Evaluation Committee. Severe community-acquired pneumonia as a cause of severe sepsis: Data from the PROWESS study. Crit Care Med 2003; 33(5): 952-961.